Aspira Women's Health INC Form 4 insider transactions

Director Stefanie L. Cavanaugh reports acquisition of 16,804 shares and disposal of 54,976 shares of Aspira Women's Health Inc. common stock on August 12, 2024, following vesting of restricted stock units.

Director Ellen O'Connor Vos reports acquisition of restricted stock units in Aspira Women's Health, which vested on August 12, 2024.

Jack Schuler, a director and 10% owner of Aspira Women's Health Inc., acquired 6,536 shares of common stock and corresponding warrants.

Director Winfred Parnell acquired 3,268 shares of Aspira Women's Health Inc. along with warrants to purchase an additional 3,268 shares.

Jannie Prestridge Herchuk, a director at Aspira Women's Health Inc., recently acquired shares and warrants of the company.

Ellen O'Connor Vos, a director of Aspira Women's Health Inc., recently acquired 3,268 shares of common stock and warrants to purchase an additional 3,268 shares.

Stefanie L. Cavanaugh, a director at Aspira Women's Health Inc., recently acquired 3,268 shares of common stock and warrants to purchase an additional 3,268 shares.

Aspira Women's Health CEO Nicole Sandford reports the acquisition of common stock and warrants.

Jack W. Schuler, a director and 10% owner of Aspira Women's Health Inc., acquired 28,500 shares of common stock and warrants through the Jack W. Schuler Living Trust on January 26, 2024.

Torsten Hombeck, CFO of Aspira Women's Health, acquired options to purchase 6,667 shares of common stock after performance conditions were met on May 3, 2024.

Aspira Women's Health CEO Nicole Sandford recently purchased 9,493 shares of company stock at an average price of $2.42.

Torsten Hombeck, CFO of Aspira Women's Health Inc., reports the acquisition of employee stock options.

Aspira Women's Health CEO Nicole Sandford was granted stock options to purchase 80,000 shares of common stock on May 13, 2024.

Sandra Milligan, President of Aspira Women's Health Inc., reports the acquisition of employee stock options.